Skip to main content

Table 1 Statistical analysis of ANGPTL4 mRNA with clinical factors of HCC patients using two-tailed T-test

From: Clinical relevance and therapeutic potential of angiopoietin-like protein 4 in hepatocellular carcinoma

  

ANGPTL4 mRNA in HCC patients

  

Tumor/non-tumor difference

Tumor

Non-tumor

Clinical factors

Number (n)

Mean (Log2)

P

Mean (Log2)

p

Mean (Log2)

p

Sex

       

  Male

88

−1.20

0.889

5.85

0.381

7.15

0.670

  Female

22

−1.12

 

6.32

 

7.02

 

Venous infiltration

       

  Absent

51

−0.67

0.023*

6.51

0.012*

7.18

0.692

  Present

59

−1.63

 

5.45

 

7.08

 

Differentiation a

       

  Moderately or well

87

−0.82

0.000***

6.21

0.013*

7.17

0.639

  Undifferentiated or poorly

18

−3.21

 

4.80

 

7.01

 

pTNM staging a

       

  Early stage

34

−0.35

0.007**

6.67

0.025*

7.04

0.646

  Advanced stage

75

−1.56

 

5.66

 

7.16

 

Cirrhosis a

       

  No cirrhosis

39

−0.97

0.479

5.98

0.981

6.98

0.382

  Cirrhosis

69

−1.29

 

5.97

 

7.20

 

Recurrence

       

  No recurrence

49

−0.69

0.035*

6.58

0.006**

7.20

0.577

  Recurrence

61

−1.58

 

5.43

 

7.07

 

Hepatitis B surface antigen

       

  Negative

16

−0.99

0.700

5.53

0.429

6.61

0.080

  Positive

94

−1.22

 

6.01

 

7.22

 
  1. aTotal number less than 110 due to missing data; *, p<0.05; **, p<0.01; ***, p<0.001.
Back to article page

Molecular Cancer

ISSN: 1476-4598